Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models. - Gruber DR; Cummins EJ; Zeng W; Ulrich M; Smith K; Long M; Spahr K; Higgins S; Hinricher K; Langalia A; Krumm K; Olson DJ; et al. (Molecular cancer therapeutics, 2026)